International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 144339 - 144339
Published: May 1, 2025
Language: Английский
International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 144339 - 144339
Published: May 1, 2025
Language: Английский
ACS Nano, Journal Year: 2024, Volume and Issue: 18(20), P. 12917 - 12932
Published: May 9, 2024
Inflammatory bowel diseases (IBDs) refer to multifaceted disorders in the intestinal microenvironment and microbiota homeostasis. In view of broad bioactivity high compatibility polyphenols, there is considerable interest developing a polyphenol-based collaborative platform remodel IBD regulate microbiota. Here, we demonstrated coordination assembly nanostructured polyphenols modify probiotics simultaneously deliver drugs for treatment. Inspired by distinctive structure tannic acid (TA), fabricated pBDT-TA using self-polymerizable aromatic dithiol (BDT) TA, which exhibited excellent antioxidant anti-inflammatory capability vitro. We thus coated sodium alginate (SA) surface Escherichia coli Nissle 1917 layer construct EcN@SA-pBDT-TA. The modified showed improved resistance oxidative inflammatory stress, resulted superior colon accumulation retention model mice. Further, EcN@SA-pBDT-TA could alleviate dextran sulfate (DSS)-induced colitis controlling response, repairing barriers, modulating gut Importantly, EcN@SA-pBDT-TA-mediated drug delivery achieve an therapeutic effect DSS Given availability functionality polyphenol prebiotics, expected that polyphenol-modified provided solution develop
Language: Английский
Citations
28Chemical Engineering Journal, Journal Year: 2024, Volume and Issue: 490, P. 151756 - 151756
Published: April 30, 2024
Language: Английский
Citations
19Advanced Composites and Hybrid Materials, Journal Year: 2025, Volume and Issue: 8(2)
Published: April 1, 2025
Language: Английский
Citations
5Gels, Journal Year: 2024, Volume and Issue: 10(5), P. 295 - 295
Published: April 25, 2024
Biomedicine is constantly evolving to ensure a significant and positive impact on healthcare, which has resulted in innovative distinct requisites such as hydrogels. Chitosan-based formulations stand out for their versatile utilization drug encapsulation, transport, controlled release, complemented by biocompatibility, biodegradability, non-immunogenic nature. Stimuli-responsive hydrogels, also known smart have strictly regulated release patterns since they respond adapt based various external stimuli. Moreover, can imitate the intrinsic tissues’ mechanical, biological, physicochemical properties. These characteristics allow stimuli-responsive hydrogels provide cutting-edge, effective, safe treatment. Constant progress field necessitates an up-to-date summary of current trends breakthroughs biomedical application chitosan-based was aim this review. General data about sensitive ions, pH, redox potential, light, electric field, temperature, magnetic are recapitulated. Additionally, responsive multiple stimuli mentioned. Focusing multifaceted thoroughly described. The vast spectrum encompasses neurological disorders, tumors, wound healing, dermal infections. Available chitosan strongly support idea that approaches developing novel solutions worth improving. present paper constitutes valuable resource researchers practitioners currently field.
Language: Английский
Citations
11International Journal of Molecular Sciences, Journal Year: 2025, Volume and Issue: 26(2), P. 575 - 575
Published: Jan. 11, 2025
Inflammatory bowel disease (IBD), encompassing Crohn's and ulcerative colitis, involves chronic inflammation of the gastrointestinal tract. Current immune-modulating therapies are insufficient for 30-50% patients or cause significant side effects, emphasizing need new treatments. Targeting innate immune system enhancing drug delivery to inflamed gut regions promising strategies. Neutrophils play a central role in IBD by releasing reactive oxygen species (ROS) neutrophil extracellular traps (NETs) -DNA-based structures with cytotoxic proteins-that contribute mucosal damage inflammation. Recent studies linking ROS production, DNA repair, NET formation have identified NETs as potential therapeutic targets, preclinical models showing positive outcomes from inhibition. Innovative oral systems designed target directly-without systemic absorption-could improve treatment precision reduce effects. Advanced formulations utilize properties such particle size, surface modifications, ROS-triggered release selectively distal ileum colon. A dual strategy that combines deeper understanding pathophysiology identify inflammation-related targets advanced may offer promise. For instance, pairing inhibition ROS-responsive nanocarriers could enhance efficacy, though further research is needed. This synergistic approach has greatly patients.
Language: Английский
Citations
2International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: unknown, P. 135775 - 135775
Published: Sept. 1, 2024
Language: Английский
Citations
9Pharmaceutics, Journal Year: 2024, Volume and Issue: 16(10), P. 1333 - 1333
Published: Oct. 17, 2024
Nanoemulsions (NEs) are submicron-sized heterogeneous biphasic liquid systems stabilized by surfactants. They physically transparent or translucent, optically isotropic, and kinetically stable, with droplet sizes ranging from 20 to 500 nm. Their unique properties, such as high surface area, small size, enhanced bioavailability, excellent physical stability, rapid digestibility, make them ideal for encapsulating various active substances. This review focuses on recent advancements, future prospects, challenges in the field of NEs, particularly oral, parenteral, ophthalmic delivery. It also discusses clinical trials patents. Different types vitro vivo NE characterization techniques summarized. High-energy low-energy preparation methods briefly described diagrams. Formulation considerations commonly used excipients ocular, drug delivery presented. The emphasizes need new functional improve permeation large molecular weight unstable proteins, oligonucleotides, hydrophilic drugs advance rapidly.
Language: Английский
Citations
9Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(3), P. 337 - 337
Published: March 5, 2025
Nanoemulsions (NEs) have emerged as effective drug delivery systems over the past few decades due to their multifaceted nature, offering advantages such enhanced bioavailability, protection of encapsulated compounds, and low toxicity. In present review, we focus on advancements in last five years across (trans)dermal, oral, ocular, nasal, intra-articular administration routes using NEs. Rational selection components, surface functionalization, incorporation permeation enhancers, functionalization with targeting moieties are explored for each route discussed. Additionally, apart from NEs, explore NE-based (e.g., gels) while highlighting emerging approaches vaccination theranostic applications. The growing interest NEs purposes is reflected clinical trials, which also By summarizing latest advances, exploring new strategies, identifying critical challenges, this review focuses developments efficient therapeutic approaches.
Language: Английский
Citations
1Molecules, Journal Year: 2024, Volume and Issue: 29(7), P. 1659 - 1659
Published: April 7, 2024
Curcumin (CCM) is a polyphenol compound extracted from the turmeric rhizome. It has various biological activities, including antibacterial, anti-inflammatory, anti-cancer, and antioxidant. Due to its diverse it often used by researchers study therapeutic effects on diseases. However, poor solubility leads bioavailability, necessary increase water with help of carriers improve effect. Gastrointestinal disease major global health problem that continues affect human health. In this review, we have summarized possible mechanism effect CCM in gastrointestinal diseases, improvement curative nanopreparation. Finally, concluded there been many clinical trials combination other drugs for treatment disease, but so far, few nanomaterials treatment. Although vitro preclinical experiments shown nanopreparations can efficacy CCM, are still insufficient studies safety carriers.
Language: Английский
Citations
6International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: 276, P. 133956 - 133956
Published: July 17, 2024
Language: Английский
Citations
6